Article
Orlando - Multi-functional products that address several causative mechanisms are the newest development in the treatment of hyperpigmentation, says Zoe Draelos, M.D.
Tralokinumab Shows Long-Term Efficacy for AD in Sensitive Areas
The Cutaneous Connection: Intervening in AD Progression for Pediatric Patients
FDA Approves sNDA for Actinic Keratosis Drug Dosage Expansion
The Cutaneous Connection: Navigating Systemic Therapies in Atopic Dermatitis
BREAKING NEWS: Additional Study Confirms Reports of Benzene Presence, Formation in Benzoyl Peroxide Products at Room Temperature
Derm In The News: September 29-October 5